| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2438500C Composition for electroporation |
| 09/08/2009 | CA2431984C Antibiotic coating for porous bodies and method for its production as well as its use |
| 09/08/2009 | CA2396344C Polymer blends as biodegradable matrices for preparing biocomposites |
| 09/08/2009 | CA2384422C Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2358493C Edible coating composition |
| 09/08/2009 | CA2263070C Oral composition |
| 09/08/2009 | CA2261799C Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 09/08/2009 | CA2224074C System and method for producing drug-loaded microparticles |
| 09/08/2009 | CA2210872C Dried composition |
| 09/07/2009 | CA2624883A1 Directed therapy |
| 09/03/2009 | WO2009108935A2 Method and apparatus for impregnating porous biomaterials with bioactive agents |
| 09/03/2009 | WO2009108891A2 Modified poloxamers for gene expression and associated methods |
| 09/03/2009 | WO2009108868A2 Radiolabeled hedgehog derivatives for imaging and therapy |
| 09/03/2009 | WO2009108828A2 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| 09/03/2009 | WO2009108806A1 Conjugated factor viii molecules |
| 09/03/2009 | WO2009108632A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 09/03/2009 | WO2009108554A2 System for delivery of protein in insoluble fibrillar or aggregate form |
| 09/03/2009 | WO2009108100A1 Composition for the formation of gels |
| 09/03/2009 | WO2009108005A2 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity |
| 09/03/2009 | WO2009107877A1 Pharmaceutical composition |
| 09/03/2009 | WO2009107766A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | WO2009107753A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 09/03/2009 | WO2009107683A1 Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent |
| 09/03/2009 | WO2009107479A1 Patch |
| 09/03/2009 | WO2009107478A1 Adhesive skin patch and packaged product |
| 09/03/2009 | WO2009107477A1 Medicated patch |
| 09/03/2009 | WO2009107476A1 Medicated patch |
| 09/03/2009 | WO2009106831A2 Pharmaceutical composition |
| 09/03/2009 | WO2009106713A2 New class of cationic lipids for transporting active agents into cells |
| 09/03/2009 | WO2009106555A2 Sterilized sucralfate gel |
| 09/03/2009 | WO2009106502A2 Implant and method for the manufacture thereof |
| 09/03/2009 | WO2009106239A1 Selenium containing modifying agents and conjugates |
| 09/03/2009 | WO2009105937A1 A vinorelbine soft capsule and its preparation method and application. |
| 09/03/2009 | WO2009105874A1 Composition and method for irrigation of a prepared dental root canal |
| 09/03/2009 | WO2009105820A1 Hydrogels derived from biological polymers |
| 09/03/2009 | WO2009069959A3 A nanoparticle for separating peptide, method for preparing the same, and method for separating peptide using the same |
| 09/03/2009 | WO2009065561A3 System for delivery into a xcr1 positive cell and uses thereof |
| 09/03/2009 | WO2009059748A3 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 09/03/2009 | WO2009059717A3 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use |
| 09/03/2009 | WO2009043031A3 Microbubbles and methods for oxygen delivery |
| 09/03/2009 | WO2009030492A3 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 09/03/2009 | WO2009027452A3 Radiopharmaceutical composition |
| 09/03/2009 | WO2009021728A3 Targeted block copolymer micelles |
| 09/03/2009 | WO2009016507A3 Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method |
| 09/03/2009 | WO2009004057A3 Mutated dimeric prolactin receptor ligands |
| 09/03/2009 | WO2009001322A3 Caspase inhibitors for treating pathologies resulting from ischemia |
| 09/03/2009 | WO2009001219A3 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 09/03/2009 | WO2008144185A3 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| 09/03/2009 | WO2008141762A3 Polymer conjugate compounds for the inhibition of apoptosis |
| 09/03/2009 | US20090221719 Base material for producing food and fodder |
| 09/03/2009 | US20090221718 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/03/2009 | US20090221717 Magnesium ammonium phosphate cement composition |
| 09/03/2009 | US20090221706 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 09/03/2009 | US20090221536 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090221489 Water-Soluable Films Comprising Low-Viscosity Alginates |
| 09/03/2009 | US20090220604 Amino acids in micelle preparation |
| 09/03/2009 | US20090220574 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 09/03/2009 | US20090220547 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 09/03/2009 | US20090220509 Singlec-9 binding agents |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220475 Bone repair material |
| 09/03/2009 | US20090220451 Cyclopropyl compounds and compositions for delivering active agents |
| 09/03/2009 | US20090220443 Compositions comprising metathesized unsaturated polyol esters |
| 09/03/2009 | US20090220436 In situ polymerization for skin treatment |
| 09/03/2009 | US20090220426 Biodegradable Inverted-Opal Structure, Method for Manufacturing and Using the Same, and Medical Implant Comprising the Biodegradable Inverted-Opal Structure |
| 09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
| 09/03/2009 | US20090218731 Shaped body and method for production of said body |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2753833A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 09/03/2009 | CA2717276A1 Selenium containing modifying agents and conjugates |
| 09/03/2009 | CA2717133A1 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 09/03/2009 | CA2717020A1 Enzyme and receptor modulation |
| 09/03/2009 | CA2716720A1 Pharmaceutical composition |
| 09/03/2009 | CA2716671A1 Implant and method for the manufacture thereof |
| 09/03/2009 | CA2716565A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | CA2716336A1 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders |
| 09/03/2009 | CA2715465A1 Conjugated factor viii molecules |
| 09/03/2009 | CA2714942A1 Stabilized single-liquid pharmaceutical composition containing docetaxel |
| 09/03/2009 | CA2714351A1 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 09/03/2009 | CA2708988A1 New class of cationic lipids for transporting active agents into cells |
| 09/02/2009 | EP2096374A2 Self-contained heating unit and drug-supply unit employing same |
| 09/02/2009 | EP2096116A1 Sodium salt of disaccharide compound, method for producing the same, and use of the same |
| 09/02/2009 | EP2095829A1 Selenium containing modifying agents and conjugates |
| 09/02/2009 | EP2095817A1 Therapeutic compositions and methods |
| 09/02/2009 | EP2095812A1 Granular preparation prevented from caking |
| 09/02/2009 | EP2094729A1 Abeta antibody parenteral formulation |
| 09/02/2009 | EP2094311A2 Improved linkers for anchoring targeting ligands |
| 09/02/2009 | EP2094309A2 Alpha-lactalbumin composition |
| 09/02/2009 | EP2094308A1 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure |
| 09/02/2009 | EP2094291A1 Dimeric prolactin receptor ligands |
| 09/02/2009 | EP2094283A1 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 09/02/2009 | EP2094281A2 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 09/02/2009 | EP2094250A1 Transdermal therapeutic system comprising ion pair micro-reservoirs |
| 09/02/2009 | EP2094247A2 Stable polypeptide formulations |
| 09/02/2009 | EP2094236A1 Gel useful for the delivery of ophthalmic drugs |
| 09/02/2009 | EP2094213A1 Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 09/02/2009 | EP1585817B1 Conjugates comprising a biodegradable polymer and uses therefor |